Free Trial

Artiva Biotherapeutics (ARTV) Institutional Ownership

Artiva Biotherapeutics logo
$3.18 +0.09 (+2.91%)
Closing price 09/3/2025 04:00 PM Eastern
Extended Trading
$3.16 -0.02 (-0.63%)
As of 09/3/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Artiva Biotherapeutics (NASDAQ:ARTV)

Number of
Institutional Buyers
(last 12 months)
25
Total
Institutional Inflows
(last 12 months)
$180.10M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$1.43M
Get ARTV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Artiva Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ARTV Institutional Buying and Selling by Quarter

Artiva Biotherapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025 Bridgeway Capital Management LLC35,000$53K0.0%N/A0.143%
8/14/2025 Jane Street Group LLC44,215$67K0.0%N/A0.181%
8/14/2025 Qube Research & Technologies Ltd38,692$58K0.0%N/A0.158%
8/13/2025 Marshall Wace LLP52,213$79K0.0%N/A0.214%
8/8/2025 Geode Capital Management LLC159,041$240K0.0%-61.3%0.653%
8/1/2025 Y Intercept Hong Kong Ltd31,567$48K0.0%N/A0.130%
7/31/2025 Ground Swell Capital LLC24,849$38K0.1%N/A0.102%
5/15/2025 venBio Partners LLC1,198,975$3.60M2.9%-21.1%4.921%
5/12/2025 Nuveen LLC47,892$144K0.0%N/A0.197%
5/9/2025 Charles Schwab Investment Management Inc.54,881$165K0.0%+26.1%0.225%
2/17/2025 Deutsche Bank AG21,423$216K0.0%N/A0.088%
2/17/2025 Bank of America Corp DE10,817$109K0.0%-39.3%0.045%
2/17/2025 BNP Paribas Financial Markets9,879$100K0.0%+262.1%0.041%
2/14/2025 Northern Trust Corp117,112$1.18M0.0%+3.8%0.482%
2/13/2025 Barclays PLC24,161$244K0.0%+23.2%0.099%
2/13/2025 Wells Fargo & Company MN8,616$87K0.0%+64.0%0.035%
2/12/2025 Geode Capital Management LLC315,758$3.18M0.0%+2.2%1.300%
2/12/2025 Norges Bank30,000$302K0.0%N/A0.124%
2/12/2025 JPMorgan Chase & Co.37,619$379K0.0%+250.7%0.155%
2/6/2025 Charles Schwab Investment Management Inc.43,526$439K0.0%+8.0%0.179%
1/30/2025 Rhumbline Advisers12,879$130K0.0%-13.1%0.053%
1/24/2025 China Universal Asset Management Co. Ltd.5,150$52K0.0%N/A0.021%
12/26/2024 JPMorgan Chase & Co.10,726$166K0.0%N/A0.044%
11/27/2024 Franklin Resources Inc.520,301$7.44M0.0%N/A2.142%
11/19/2024 Barclays PLC19,616$304K0.0%N/A0.081%
11/16/2024 Geode Capital Management LLC308,930$4.77M0.0%N/A1.272%
11/15/2024 Barclays PLC19,616$304K0.0%N/A0.081%
11/15/2024 Wellington Management Group LLP194,108$2.91M0.0%N/A0.799%
11/15/2024 State Street Corp86,559$1.34M0.0%N/A0.356%
11/15/2024 Samsara BioCapital LLC291,666$4.51M0.9%N/A1.201%
11/15/2024 RA Capital Management L.P.9,853,302$152.23M1.8%N/A40.565%
11/15/2024 RTW Investments LP148,844$2.30M0.0%N/A0.613%
11/14/2024 Acuta Capital Partners LLC44,000$680K0.6%N/A0.181%
11/14/2024 MetLife Investment Management LLC8,733$135K0.0%N/A0.036%
11/13/2024 BNP Paribas Financial Markets2,728$42K0.0%N/A0.011%
11/12/2024 Charles Schwab Investment Management Inc.40,293$623K0.0%N/A0.166%
(Data available from 1/1/2016 forward)

ARTV Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ARTV shares?

During the previous two years, 28 institutional investors and hedge funds held shares of Artiva Biotherapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($152.23M), Franklin Resources Inc. ($7.44M), Samsara BioCapital LLC ($4.51M), venBio Partners LLC ($3.60M), Wellington Management Group LLP ($2.91M), RTW Investments LP ($2.30M), and State Street Corp ($1.34M).Learn more on Artiva Biotherapeutics' institutional investors.

Which institutional investors have been buying Artiva Biotherapeutics' stock?

Of the 25 institutional investors that purchased Artiva Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($9.85M), Franklin Resources Inc. ($520.30K), Geode Capital Management LLC ($315.76K), Samsara BioCapital LLC ($291.67K), Wellington Management Group LLP ($194.11K), RTW Investments LP ($148.84K), and State Street Corp ($86.56K).

How much institutional buying is happening at Artiva Biotherapeutics?

Institutional investors have bought a total of 11,948,124 shares in the last 24 months. This purchase volume represents approximately $180.10M in transactions.

Which of Artiva Biotherapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Artiva Biotherapeutics stock in the last 24 months: venBio Partners LLC ($321.00K), Geode Capital Management LLC ($251.42K), Bank of America Corp DE ($7.00K), and Rhumbline Advisers ($1.95K).

How much institutional selling is happening at Artiva Biotherapeutics?

Institutional investors have sold a total of 581,363 shares in the last 24 months. This volume of shares sold represents approximately $1.43M in transactions.



This page (NASDAQ:ARTV) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners